Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.
about
Human growth hormone and glutamine for patients with short bowel syndromeGuidelines for management of patients with a short bowelThe effects of long-term total parenteral nutrition on gut mucosal immunity in children with short bowel syndrome: a systematic reviewNew approaches to increase intestinal length: Methods used for intestinal regeneration and bioengineeringInsulin-like growth factors in the gastrointestinal tract and liver[Example of safety measures for antineoplastic agents immediately after market launch--a case of TS-1 capsule all example use result investigation that executes safety monitoring--].Intestinal mucosal adaptation.Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.Emerging treatment options for short bowel syndrome: potential role of teduglutideIntestinal adaptation after massive intestinal resection.Net digestive absorption and adaptive hyperphagia in adult short bowel patients.Intestinal rehabilitation and the short bowel syndrome: part 2.Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I.Intestinal rehabilitation: a management program for short-bowel syndrome.Somatropin for the treatment of short bowel syndrome in adults.Short bowel syndrome: clinical guidelines for nutrition management.Criteria for the use of recombinant human growth hormone in short bowel syndrome.Effects of bowel rehabilitation and combined trophic therapy on intestinal adaptation in short bowel patients.Intestinal mucosal atrophy and adaptationNew growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome.Nutrient intake from habitual oral diet in patients with severe short bowel syndrome living in the southeastern United States.Twenty years of recombinant human growth hormone in children: relevance to pediatric care providers.Pediatric intestinal failure: nutrition, pharmacologic, and surgical approaches.Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticityTreatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin)siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.Effects of recombinant human growth hormone on enterocutaneous fistula patients.Growth factors: possible roles for clinical management of the short bowel syndrome.Complications of enterocutaneous fistulas and their management.The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.Where are we at with short bowel syndrome and small bowel transplant.Intestinal adaptation following resection.Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.Growth hormone for intestinal adaptation in patients with short bowel syndrome: systematic review and meta-analysis of randomized controlled trialsThe pharmacologic treatment of short bowel syndrome: new tricks and novel agents.[Short bowel syndrome in Germany. Estimated prevalence and standard of care].Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.Effect of growth hormone, hyperbaric oxygen and combined therapy on the gastric serosa.Novel agents in the treatment of intestinal failure: humoral factors.Effect of recombinant human growth hormone and enteral nutrition on short bowel syndrome.
P2860
Q24234876-23BD2F7C-D1DA-4E74-A12C-EA0BB884EB62Q24646515-87D50790-BCFC-4988-A918-FBD6023568E5Q24793103-0D8AD483-E554-4256-838A-4BD0498FC14EQ26751487-0DCBD819-2FA2-4E21-8E92-884DC2C011CFQ26998926-DBE34928-C3BE-412E-AA38-FCC8069CB19CQ33369915-CE07537E-8E21-4935-97E4-5446D55813CCQ33867801-1826382A-17B9-4591-9692-244B026B3982Q34726758-4F9ADFF7-2182-48E3-9A4A-4CA609B6C1DBQ35304614-588E9F80-70FC-433D-A72E-DD42F31E4053Q35521421-C54B4742-7481-4E0B-9470-4498A2A7ED09Q35596782-3EDAB8D2-0340-4BFD-9DCC-962CF1BC5273Q35872056-7CDB0727-7F55-493C-A78E-FD7F36F121B7Q35997118-51D9847D-34CD-4AF1-AFAF-2F6EF8A40E4DQ36016254-7FA30532-1179-43A1-BE29-E73C1D88896DQ36222078-5572AEC2-3328-4494-AFAD-1123685421D5Q36278442-9E8929A8-9D9E-4E5B-BC6B-9E3D12F37ECFQ36278446-A8BC30C1-58C6-4B25-A644-736B52FAF04DQ36308924-3C5A2A53-622A-4684-BFB0-A06CDA9B0BA6Q36429803-718635F4-EF1E-4589-A87D-338FDFACF160Q36489336-D99A685D-2B70-410D-B54B-977EDF4D03DCQ36740253-FABF4844-76F7-499F-AA06-B2B3BB055B05Q36809575-BC4414FC-D0F5-4502-B8D5-C3C032086334Q37016607-C7CCEBDD-48E4-4A81-ACB5-4CD38D9638A7Q37122381-4036BC58-0B8D-46CE-ADAD-3E6FE4D195E7Q37307824-9221B046-47D4-4FCD-847E-18899E854F0EQ37358681-6CA79CBA-6EC0-409F-800F-DAA7947B53F4Q37413291-6BC03BBC-0F57-4DF7-BFFF-8038A5C19760Q37685500-84603ABC-7A30-4EE0-9090-D8C54F76964CQ37925493-43B141BB-E856-4FA9-B516-6F47352E0847Q38101129-4EA4A573-22AC-4EEF-9E0E-7FBE11F423CFQ38156844-7D1B5249-B58D-4587-8284-669DE1C17FEBQ38192586-90ED67C4-3B30-4D7E-8634-2B8DED3804B0Q38194971-0F4AF138-2636-475A-81BA-54F37DA642E0Q38197594-74C46336-42A2-4B82-B736-3E25398C9D95Q38232874-0E8B2E47-03C5-4C12-9479-75DF05EE2F5FQ38403047-68736497-6EB9-4ED3-906F-2A7627A6D91DQ40464793-B96C0ED4-E28A-4EB0-BD44-E4A1A580E547Q40918260-746ED15E-B67B-4152-9EF5-C7A3BC878161Q42410575-A5DCA8D8-E298-45EE-9401-D35EB4B704E6Q45165490-4EE3466D-A548-41F2-BFDC-12699B4EB588
P2860
Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Low-dose growth hormone in adu ...... me patients: a positive study.
@en
Low-dose growth hormone in adu ...... me patients: a positive study.
@nl
type
label
Low-dose growth hormone in adu ...... me patients: a positive study.
@en
Low-dose growth hormone in adu ...... me patients: a positive study.
@nl
prefLabel
Low-dose growth hormone in adu ...... me patients: a positive study.
@en
Low-dose growth hormone in adu ...... me patients: a positive study.
@nl
P2093
P356
P1433
P1476
Low-dose growth hormone in adu ...... ome patients: a positive study
@en
P2093
Bernard Messing
Jean-Claude Souberbielle
Kouroche Vahedi
Nathalie Kapel
P304
P356
10.1053/GAST.2003.50057
P407
P50
P577
2003-02-01T00:00:00Z